- Allergan says court affirms patent loss to Sandoz on eye drug Nasdaq
- UPDATE 1-Allergan says court affirms patent loss to Sandoz on eye drug Reuters
- Allergan (AGN) Acknowledges Appeals Court Decision for COMBIGAN Patents StreetInsider.com
Full coverage
|